May 24, 2022 / 08:00PM GMT
Presentation at Digestive Disease Week Call
May 24, 2022 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer
* Michael Corbo
Pfizer Inc. - Chief Development Officer, Inflammation & Immunology
* Michael S. Vincent
Pfizer Inc. - Senior VP and Chief Scientific Officer, Inflammation & Immunology
* Mike Gladstone
Pfizer Inc. - Global President, Inflammation & Immunology
* Sheldon Sloan
Arena Pharmaceuticals Inc. - Vice President, Etrasimod UC Team Lead
=====================
Conference Call Participants
=====================
* Brian Tsang
Wolfe Research, LLC - Research Analyst
* Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
* Evan David Seigerman
BMO Capital Markets Equity Research - MD & Senior BioPharma Research Analyst
* Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Pfizer Inc
(NEOE:ZPFE)
C$
9.93
(0%)
Market Cap: 56.60 Bil
Enterprise Value: 127.76 Bil
PE Ratio: 18.54
PB Ratio: 1.54
GF Score: 57/100 Pfizer Inc Analyst and Investor Call to Discuss Etrasimod Data Presentation at Digestive Disease Week Call Transcript
May 24, 2022 / 08:00PM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot